4I1S image
Deposition Date 2012-11-21
Release Date 2013-01-30
Last Version Date 2024-11-06
Entry Detail
PDB ID:
4I1S
Title:
Melanoma differentiation associated protein-5 Helicase domain complex with inhibitor Non-structural protein V
Biological Source:
Source Organism:
Sus scrofa (Taxon ID: 9823)
Simian virus 5 (Taxon ID: 11208)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.29 Å
R-Value Free:
0.22
R-Value Work:
0.17
R-Value Observed:
0.18
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Melanoma differentiation associated protein-5
Gene (Uniprot):MDA5
Chain IDs:A
Chain Length:243
Number of Molecules:1
Biological Source:Sus scrofa
Polymer Type:polypeptide(L)
Molecule:Non-structural protein V
Gene (Uniprot):P/V
Chain IDs:B
Chain Length:52
Number of Molecules:1
Biological Source:Simian virus 5
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
MSE A MET SELENOMETHIONINE
Ligand Molecules
Primary Citation
Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling.
Science 339 690 693 (2013)
PMID: 23328395 DOI: 10.1126/science.1230949

Abstact

The retinoic acid-inducible gene I (RIG-I)-like receptor (RLR) melanoma differentiation-associated protein 5 (MDA5) senses cytoplasmic viral RNA and activates antiviral innate immunity. To reveal how paramyxoviruses counteract this response, we determined the crystal structure of the MDA5 adenosine 5'-triphosphate (ATP)-hydrolysis domain in complex with the viral inhibitor V protein. The V protein unfolded the ATP-hydrolysis domain of MDA5 via a β-hairpin motif and recognized a structural motif of MDA5 that is normally buried in the conserved helicase fold. This leads to disruption of the MDA5 ATP-hydrolysis site and prevention of RNA-bound MDA5 filament formation. The structure explains why V proteins inactivate MDA5, but not RIG-I, and mutating only two amino acids in RIG-I induces robust V protein binding. Our results suggest an inhibition mechanism of RLR signalosome formation by unfolding of receptor and inhibitor.

Legend

Protein

Chemical

Disease

Primary Citation of related structures